INM vs LHX · rev $4.9M vs P/E 34, rev $5.88B
InMed Pharmaceuticals Inc (INM) versus L3Harris Technologies Inc (LHX) — a side-by-side from cached financials, not a winner call.
InMed Pharmaceuticals Inc (INM) is a drug manufacturers - specialty & generic company listed on US.
L3Harris Technologies Inc (LHX) is a aerospace & defense company listed on US.
Latest reported INM revenue for 2025-06-30 was $4.9M. Net income was -$8.2M. INM currently screens at market cap $5.2M.
Latest reported LHX revenue for 2026-07-03 was $5.88B. Net income was $600.0M. Revenue was up 2.4% from 2026-04-03 to 2026-07-03. LHX currently screens at market cap $58.72B and trailing P/E 34.3.
INM currently screens at market cap $5.2M. LHX currently screens at market cap $58.72B and trailing P/E 34.3.
Not investment advice. Open the INM and LHX stock pages for the full models.
Not investment advice.